CAS Medical Systems, Inc. (CASM) EPS Estimated At $-0.08

April 20, 2018 - By Stephen Andrade

CAS Medical Systems, Inc. (NASDAQ:CASM) LogoInvestors sentiment increased to 1 in 2017 Q4. Its up 0.17, from 0.83 in 2017Q3. It is positive, as 2 investors sold CAS Medical Systems, Inc. shares while 3 reduced holdings. 3 funds opened positions while 2 raised stakes. 6.42 million shares or 0.78% more from 6.37 million shares in 2017Q3 were reported.
Vanguard invested in 0% or 531,881 shares. Northern Tru holds 0% or 25,101 shares in its portfolio. Two Sigma Secs Limited Liability holds 0% or 24,346 shares. 5.16 million were accumulated by Acuta Capital Prtnrs Limited Liability Co. Renaissance Technologies Lc reported 270,000 shares. Hightower Ltd Liability Company holds 245,489 shares or 0% of its portfolio. Penbrook Mgmt Limited Company holds 33,600 shares or 0.02% of its portfolio. Guggenheim Capital Ltd invested 0% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM). California Public Employees Retirement holds 0% or 10,400 shares. Td Mgmt Limited Co stated it has 0.01% in CAS Medical Systems, Inc. (NASDAQ:CASM). Wells Fargo Com Mn invested in 227 shares or 0% of the stock. Blackrock holds 12,062 shares. Royal Comml Bank Of Canada reported 0% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM). Morgan Stanley owns 721 shares or 0% of their US portfolio. Citadel Advsr Ltd Llc has invested 0% in CAS Medical Systems, Inc. (NASDAQ:CASM).

Since March 15, 2018, it had 0 insider purchases, and 1 sale for $3,489 activity.

Analysts expect CAS Medical Systems, Inc. (NASDAQ:CASM) to report $-0.08 EPS on May, 2.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.08 EPS. After having $-0.07 EPS previously, CAS Medical Systems, Inc.’s analysts see 14.29 % EPS growth. The stock decreased 2.56% or $0.03 during the last trading session, reaching $1.14. About 38,853 shares traded or 80.75% up from the average. CAS Medical Systems, Inc. (NASDAQ:CASM) has declined 14.97% since April 20, 2017 and is downtrending. It has underperformed by 26.52% the S&P500.

CAS Medical Systems, Inc., a non-invasive cerebral oximetry technology company, develops, makes, and markets non-invasive patient monitoring products worldwide. The company has market cap of $31.27 million. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive and continuous measurement of absolute cerebral tissue oxygenation in the brain for patients during critical care. It currently has negative earnings. The firm provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories.

CAS Medical Systems, Inc. (NASDAQ:CASM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: